These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 27096417)

  • 21. Profiling of gastric cancer cell-surface markers to achieve tumour-normal discrimination.
    Toh J; Hoppe MM; Thakur T; Yang H; Tan KT; Pang B; Ho S; Roy R; Ho KY; Yeoh KG; Tan P; Sundar R; Jeyasekharan A
    BMJ Open Gastroenterol; 2020 Aug; 7(1):. PubMed ID: 32816956
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preoperative hCGbeta and CA 72-4 are prognostic factors in gastric cancer.
    Louhimo J; Kokkola A; Alfthan H; Stenman UH; Haglund C
    Int J Cancer; 2004 Oct; 111(6):929-33. PubMed ID: 15300805
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of tumor M2-pyruvate kinase (tumor M2-PK), carcinoembryonic antigen (CEA), carbohydrate antigens CA 19-9 and CA 72-4 in the diagnosis of gastrointestinal cancer.
    Schneider J; Schulze G
    Anticancer Res; 2003; 23(6D):5089-93. PubMed ID: 14981971
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Utility of Nasogastric Tube for Medical and Surgical Oncology of Gastric Cancer: A Prospective Institutional Study on a New and Precious Application of an Old and Economic Device.
    Virgilio E; Balducci G; Mercantini P; Giarnieri E; Giovagnoli MR; Montagnini M; Proietti A; D'Urso R; Cavallini M
    Anticancer Res; 2018 Jan; 38(1):433-439. PubMed ID: 29277806
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumor markers CA 125, carcinoembryonic antigen and tumor-associated trypsin inhibitor in patients with cervical adenocarcinoma.
    Leminen A
    Gynecol Oncol; 1990 Dec; 39(3):358-63. PubMed ID: 2258083
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic significance of tumor markers in peritoneal lavage in advanced gastric cancer.
    Yamamoto M; Baba H; Kakeji Y; Endo K; Ikeda Y; Toh Y; Kohnoe S; Okamura T; Maehara Y
    Oncology; 2004; 67(1):19-26. PubMed ID: 15459491
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The prognostic significance of gastric juice CA 19-9 and CEA levels in gastric carcinoma patients.
    Duraker N; Naci Celik A; Gençler N
    Eur J Surg Oncol; 2002 Dec; 28(8):844-9. PubMed ID: 12477476
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic value of preoperative CEA, CA 19-9, CA 72-4, and AFP levels in gastric cancer.
    Ucar E; Semerci E; Ustun H; Yetim T; Huzmeli C; Gullu M
    Adv Ther; 2008 Oct; 25(10):1075-84. PubMed ID: 18821070
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Investigation of serum tumor markers in the diagnosis of gastric cancer.
    Fan B; Xiong B
    Hepatogastroenterology; 2011; 58(105):239-45. PubMed ID: 21510322
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Assay of serum carbohydrate antigen (CA) 19-9 in the diagnosis of gastric cancer].
    Nishida K; Yamamoto T; Yoshioka K; Iida M; Miyagawa H; Yoshikawa T; Sugino S; Kondo M
    Gan To Kagaku Ryoho; 1986 Jan; 13(1):101-8. PubMed ID: 3455804
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The tumor markers CEA, TPA and CA 19-9 in gastric cancer.
    Putzki H; Reichert B; Jablonski M; Heymann H
    Dtsch Z Verdau Stoffwechselkr; 1988; 48(3-4):145-8. PubMed ID: 3234297
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum CA 19-9, SLX, STN and CEA levels of the peripheral and the draining venous blood in gastric cancer.
    Imada T; Rino Y; Takahashi M; Hatori S; Shiozawa M; Amano T; Kondo J
    Hepatogastroenterology; 1999; 46(27):2086-90. PubMed ID: 10430402
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical utility of CA 72-4 serum marker in the staging and immediate post-surgical management of gastric cancer patients.
    Spila A; Roselli M; Cosimelli M; Ferroni P; Cavaliere F; Arcuri R; Tedesco M; Carlini S; D'Alessandro R; Perri P; Casciani CU; Greiner JW; Schlom J; Guadagni F
    Anticancer Res; 1996; 16(4B):2241-7. PubMed ID: 8694550
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The changes in tumor markers such as serum CEA, CA 19-9, TPA and CA 125 in the chemotherapy of patients with advanced gastric cancer].
    Imamura Y; Yasutake K; Yoshimura Y; Oya M; Matsushita K; Tokisue M; Ohno S; Masuda T
    Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 1):1501-7. PubMed ID: 2143888
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The usefulness of CEA and/or CA19-9 in monitoring for recurrence in gastric cancer patients: a prospective clinical study.
    Takahashi Y; Takeuchi T; Sakamoto J; Touge T; Mai M; Ohkura H; Kodaira S; Okajima K; Nakazato H;
    Gastric Cancer; 2003; 6(3):142-5. PubMed ID: 14520526
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The use of tumor markers as predictors of prognosis in gastric cancer.
    Mihmanli M; Dilege E; Demir U; Coskun H; Eroglu T; Uysalol MD
    Hepatogastroenterology; 2004; 51(59):1544-7. PubMed ID: 15362797
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The evaluation of diagnostic value of the tumor markers: CCSA-2 and CEA in colorectal cancer.
    Knychalski B; Lukieńczuk T
    Pol Przegl Chir; 2012 Feb; 84(2):86-92. PubMed ID: 22487741
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic value of early postoperative tumor marker response in gastric cancer.
    Nam DH; Lee YK; Park JC; Lee H; Shin SK; Lee SK; Lee YC; Cheong JH; Hyung WJ; Noh SH; Kim CB
    Ann Surg Oncol; 2013 Nov; 20(12):3905-11. PubMed ID: 23807661
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Elevated Gastric Juice Carbohydrate Antigen 72.4 (Ca 72.4) Is an Independent Prognostic Factor of Poor Survival for Gastric Cancer Patients.
    Virgilio E; Proietti A; D'Urso R; Cardelli P; Giarnieri E; Giovagnoli MR; Montagnini M; Villani S; Balducci G; Cavallini M
    Anticancer Res; 2020 Mar; 40(3):1691-1695. PubMed ID: 32132076
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic information derived from RT-PCR analysis of peritoneal fluid in gastric cancer patients: results from a prospective multicenter clinical trial.
    Tamura S; Fujiwara Y; Kimura Y; Fujita J; Imamura H; Kinuta M; Yano M; Hiratsuka M; Kobayashi K; Okada K; Mori M; Doki Y
    J Surg Oncol; 2014 Feb; 109(2):75-80. PubMed ID: 24155213
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.